Research into chronic inflammatory demyelinating polyradiculoneuropathy

 Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis. Yan W, Nguyen T, Yuki N, Ji Q, Yiannikas C, Pollard JD, Mathey EK.

J Neuroimmunol. 2014

 Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy. Sung JY, Tani J, Park SB, Kiernan MC, Lin CS.

Brain. 2014 August

Reply: Biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.

Park SB, Sung JY, Tani J, Kiernan MC, Lin CS.

Brain. 2014 September

 Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era. Ware TL, Kornberg AJ, Rodriguez-Casero MV, Ryan MM.

J Child Neurol. 2014

 Chronic inflammatory demyelinating polyneuropathy. Mathey EK, Pollard JD.

J Neurol Sci. 2013

 Atypical childhood chronic inflammatory demyelinating polyneuropathy. Mohamed AR, Rodriguez-Casero MV, Ryan MM.

Muscle Nerve. 2010

 Understanding the consequences of cidp from impairments to activity and participation restrictions and reduced quality of life: the ICE study.   Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C; ICE Study Group.

 Hematopoietic Stem Cell Support in Chronic Inflammatory Demyelinating Polyneuropathy

 Randomized controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC Trial) By Richard Hughes Professor of Neurology Chief Investigator RMC Trial Kings College London School of Medicine Guy’s Hospital London


Research and development at Socialstyrelsen Sweden - Neurology Clinic at Karolinska University Hospital and Linköping University Hospital are conducting research projects on CIDP.

 Clinical Trials

CIDP at Medpedia Clinical Trials - a platform for searching clinical trials by specific condition


Make a Free Website with Yola.